These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1309042)

  • 1. Thrombin, a link between coagulation activation and fibrinolysis.
    Bertina RM; van Tilburg NH; de Fouw NJ; Haverkate F
    Ann N Y Acad Sci; 1992 Dec; 667():239-48. PubMed ID: 1309042
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
    Minix R; Doctor VM
    Thromb Res; 1997 Sep; 87(5):419-29. PubMed ID: 9306616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
    Li N; He S; Blombäck M; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
    Nielsen VG; Kirklin JK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
    Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
    Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD.
    Pinomäki A; Volin L; Joutsi-Korhonen L; Virtanen JO; Lemponen M; Ruutu T; Lassila R
    Bone Marrow Transplant; 2010 Apr; 45(4):730-7. PubMed ID: 19718071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lagopsis supina extract and its fractions exert prophylactic effects against blood stasis in rats via anti-coagulation, anti-platelet activation and anti-fibrinolysis and chemical characterization by UHPLC-qTOF-MS/MS.
    Yang L; He J
    Biomed Pharmacother; 2020 Dec; 132():110899. PubMed ID: 33096352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.
    Napolitano F; Montuori N
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications of bleeding time and intensity of prothrombin consumption and of fibrinolysis in rats after administration of platelet extracts alone and with antifibrinolytic agents.
    De Nicola P; Lüscher EF; Soardi F; Gibelli A; Cipolli PL
    Farmaco Sci; 1967 Aug; 22(8):627-40. PubMed ID: 6077137
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemostasis imbalance in experimental hypertension.
    Corseaux D; Ollivier V; Fontaine V; Huisse MG; Philippe M; Louedec L; Vranckx R; Ravanat C; Lanza F; Angles-Cano E; Guillin MC; Michel JB
    Mol Med; 2002 Apr; 8(4):169-78. PubMed ID: 12149566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro.
    Ku SK; Yoon EK; Lee W; Kwon S; Lee T; Bae JS
    Arch Pharm Res; 2016 Mar; 39(3):398-408. PubMed ID: 26762345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic activities of epi-sesamin in vitro and in vivo.
    Ku SK; Kim JA; Han CK; Bae JS
    Am J Chin Med; 2013; 41(6):1313-27. PubMed ID: 24228603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.